Brind.

Chris Kim was appointed CEO of Liminatus Pharma Inc. on July 24, 2025. Digital Offering LLC serves as the placement agent and is an SEC-registered broker-dealer.

2 reports, 1 independent Updated Jul 24

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Chris Kim was appointed CEO of Liminatus Pharma Inc. on July 24, 2025. Digital Offering LLC serves as the placement agent and is an SEC-registered broker-dealer.

Who's involved

What this event is mainly about

Chris Kim SEC

Keep exploring

The entities involved

Chris Kim
researcher

Nothing else this week.
SEC
Slovak company
- DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
- The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Coverage

Newest first; wire copies grouped

Jul 24GlobeNewswireLiminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths
Jul 23GlobeNewswireLiminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy Preclinical-stage biotech company explores digital asset treasury opportunities to enhance capital efficie